The surface antigen CD163 is used for the identification of M2 macrophages, which are considered “bad” macrophages because they participate in Th2 immune response and can release anti-inflammatory cytokines able to promote tumor development [14], although there is evidence that CD163 is not a M2-specific marker [31]. This evidence concerns the gene CD163 and neoplasm.